Self-driven immune checkpoint blockade and spatiotemporal-sensitive immune response monitoring in acute myeloid leukemia using an all-in-one turn-on bionanoprobe-Reference-Cited by-同舟云学术

Self-driven immune checkpoint blockade and spatiotemporal-sensitive immune response monitoring in acute myeloid leukemia using an all-in-one turn-on bionanoprobe

Published:2023 Issue:44 Volume:11 Page:10613-10624
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Zhang Dangui¹²,Wu Honglian³,Wang Tianci¹,Wang Yuting¹,Liu Sixi¹,Wen Feiqiu¹,Oudeng Gerile¹^ORCID,Yang Mo³^ORCID

Affiliation:

1. Department of Hematology and Oncology, Shenzhen Children's Hospital of Shantou University Medical College, Futian, Shenzhen, Guangdong, 518026, P. R. China

2. Research Center of Translational Medicine, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, 515041, P. R. China

3. Department of Biomedical Engineering, Hong Kong Polytechnic University, Hung Hom, Kowloon, 999077, Hong Kong SAR, P. R. China

Abstract

An all-in-one bionanoprobe was developed for self-driven immune checkpoint blockade and spatiotemporal-sensitive immune response monitoring in heterogeneous acute myeloid leukemia cells.

Funder

National Natural Science Foundation of China

Shenzhen Science and Technology Innovation Program

Guangdong Medical Research Foundation

Research Grants Council, University Grants Committee

Hong Kong Polytechnic University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2023/TB/D3TB01553J

Reference50 articles.

1. The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017

2. Advances in acute myeloid leukemia

3. Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy

4. The blockade of immune checkpoints in cancer immunotherapy

5. Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies